Halda Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating HLD-0915 in Metastatic Castration-Resistant Prostate Cancer
Sci x Sci-Fi Kickoff & Fireside Discussion with Annalee Newitz and Carl Zimmer: Writing and Building a Sustainable Future 03/31/2025 4:00PM—5:00PM